PubMed
Impact Factor 4.4

SAGE Publishing

Multiple Sclerosis Journal

Indexed in MEDLINE (PubMed). Published by SAGE Publishing.

An international journal covering multiple sclerosis, neuromyelitis optica and related autoimmune diseases of the central nervous system. It publishes biological, epidemiological, genetic, clinical, imaging, therapeutic and rehabilitation research.
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 15 Nov 2026

Publishing in Multiple Sclerosis Journal

Multiple Sclerosis Journal publishes research on multiple sclerosis, neuromyelitis optica and related autoimmune diseases of the central nervous system. Its scope includes biology, pathology, epidemiology, genetics, clinical neurology, neuroimaging, trials, therapeutics and rehabilitation. Article types include original research, short reports, topical reviews, case reports, viewpoints, perspectives, controversies, letters and invited editorials.

Authors can publish without a fee through the subscription route, while optional open access costs £3,454. Topical reviews can be submitted, although they are generally invited, while editorials are commissioned. The journal does not solicit systematic reviews. It states a median peer review time of 29 days and accepts 20.5% of submissions. Peer review is single blind and normally uses two independent reviewers.

Free subscriber access

Free with a subscription: the author guide in one place

Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.

  • Original Research Paper

    Original studies across the biological, clinical, imaging and therapeutic aspects of multiple sclerosis and related central nervous system diseases.

    Words
    3,000
    Abstract
    200
    Figures & tables
    8
    References
    35
    Structured abstract
  • Short Report

    Concise original research that can be reported within a short manuscript and no more than two figures or tables.

    Words
    1,000
    Abstract
    100
    Figures & tables
    2
    References
    10
  • Topical Review

    Focused factual updates on recent advances, from basic neuroscience to clinical and applied research.

    Words
    2,500
    Abstract
    150
    Figures & tables
    8
    References
    35
  • Controversies in Multiple Sclerosis

    Contrasting evidence based views on a current multiple sclerosis debate, followed by a summary.

    Words
    1,000
    Abstract
    —
    Figures & tables
    2
    References
    10
  • Personal Viewpoint

    New ideas or discussion about important multiple sclerosis studies and issues of general interest.

    Words
    1,500
    Abstract
    —
    Figures & tables
    2
    References
    10
  • Future Perspectives

    Group perspectives on improving or updating fundamentally important areas of multiple sclerosis research and practice.

    Words
    1,500
    Abstract
    —
    Figures & tables
    2
    References
    10
  • Case Report

    Cases that illustrate an important point in multiple sclerosis or related central nervous system disease.

    Words
    1,000
    Abstract
    100
    Figures & tables
    2
    References
    10
  • Letter to the Editor

    Brief discussion of a published paper or a standalone topic of interest.

    Words
    500
    Abstract
    —
    Figures & tables
    —
    References
    10
  • Invited Editorial

    Commissioned commentary on a topic related to one or more papers in an issue.

    Words
    1,000
    Abstract
    —
    Figures & tables
    —
    References
    10

There is no fee to submit or publish through the subscription route. Optional open access costs £3,454. Institutional agreements may discount or cover the fee. Requested colour printing can cost extra, while online colour is free.

Before you submit

  • Upload the relevant EQUATOR reporting checklist with the submission.
  • Register clinical trials in a WHO approved public registry and include the registration details in the abstract.
  • Include a Statements and Declarations section, even where an item is not applicable.
  • Add a funding statement even when the work received no funding.
  • Do not embed tables or figures in the main manuscript file.
  • If the manuscript is a preprint, provide its DOI and do not update it during peer review.

Present it first.

Similar journals.

Frequently asked

Is Multiple Sclerosis Journal indexed in PubMed?
Yes. Multiple Sclerosis Journal is indexed in MEDLINE, so its articles are in PubMed with a PMID.
How much does it cost to publish in Multiple Sclerosis Journal?
There is a free route: authors can publish without a fee. Open access costs £3,454.
Does Multiple Sclerosis Journal accept case reports?
Yes. Multiple Sclerosis Journal publishes case reports.
What is the Impact Factor of Multiple Sclerosis Journal?
Multiple Sclerosis Journal states an Impact Factor of 4.4 for 2025.
How long does Multiple Sclerosis Journal take to decide?
About 29 days from submission to first decision.
What is the acceptance rate of Multiple Sclerosis Journal?
Multiple Sclerosis Journal states that it accepts 20.5% of submissions.
What kind of peer review does Multiple Sclerosis Journal use?
Single-blind peer review.

MEDLINE · Free route · First decision in 29 days

Accepted work
Original research · Case report · Literature review
Acceptance rate
20.5%
Peer review
Single-blind
Access
Subscription, with an open access option · Subscribe ↗
Author guide

Checked against the journal’s author guide · updated 15 Nov 2026